In addition to their dramatic effects on blood sugar control and weight loss, GLP-1 receptor agonists (GLP-1 RAs) , the class of drugs including multi-billion blockbusters such as semaglutide (Ozempic) and tirzepatide (Mounjaro, Zepbound), have shown intriguing benefits beyond metabolism
Shortages have plagued semaglutide and tirzepatide launches
Are GLP-1 drugs genuinely transformative, or are we still in the hype phase
Increased adverse metabolic effects (diabetes, weight gain, dyslipidemia, and increased cardiovascular risk) are common during neuropsychiatric drug treatment [36]
Cataract is the leading cause of blindness, accounting for 50% of blindness worldwide [1]
Blood sugar control: Semaglutide helps control blood sugar levels by releasing insulin when blood sugar is high